
The Future of Medicine Shaped
by Cutting-Edge Cell Design Technology
The Research Institute for Cell Design Medical Science (RICeD) aims to become an international research and development center that successively creates seeds for the next-generation cell and gene therapies, through innovative cell design technologies, which are core strength of Yamaguchi University. RICeD also aims to promote the practical application of cutting-edge immunotherapy and genome medicine based on our innovative technologies, to develop treatments for intractable diseases such as cancer and genetic diseases, and to apply and verify these innovative therapies in companion animals. By creating an active cycle in which knowledge gained in humans and companion animals is fed back to each other, RICeD will endeavor to form a drug discovery ecosystem through the social implementation of the created technologies, contribute to local communities and foster human resources through the creation of industries, and extend the healthy lifespan of both humans and companion animals.
- ALL
- News
- Thesis
- Recruiting

News
2025.06.13
*Report* Associate Professor Anthony Tosi of Kent State University Visits Kogushi Campus

News
2025.06.11
*Report* External Lecturer Seminar (Division of Advanced Genome Editing Therapy) was held.

News
2025.05.28
*Information* Seminar co-hosted with the Department of Systems Bioinformatics on June 17

News
2025.05.27
*Report* The 1st Research Institute for Cell Design Medical Science Colloquium was held

News
2025.05.26
*Information* Why can newts “super-regenerate”? Molecular Mechanisms of Organ Regeneration will be held on June 10.
.png)
News
2025.05.23
*Information* We will hold an in-house seminar “Development of Gastroenterological, Breast and Endocrine Surgery” on Tuesday, June 17
.png)
News
2025.04.23
*Announcement* Phase I/IIa Clinical Trial of Human (Allogeneic) Subcutaneous Adipose Tissue-Derived Mesenchymal Stem Cell Sheet (PAL-222) Transplantation in Neovascular Age-Related Macular Degeneration Refractory to Existing Treatments (Trial Title: PRESERVE Study)

News
2025.04.04
*Announcement* Crowdfunding Goal Reached

Thesis
2025.06.12
Riboflavin transporter: Evidence of a role as entry receptor for chimpanzee endogenous retrovirus

Thesis
2025.06.06
Single bolus injection of nicotinamide mono nucleotide increases systemic insulin sensitivity in association with activation of NAD salvage pathway in the liver and adipose tissue in mice

Thesis
2025.06.05
MXene-Integrated Contact Lens: A Breakthrough in Wearable Eye Protection and Healthcare.

Thesis
2025.05.22
Small nuclear ribonucleoprotein autoantibody associated with blood-nerve barrier breakdown in Guillain-Barré syndrome

Thesis
2025.05.19
Two distinct mechanisms of PP2A regulation by methylesterase PME-1 are both essential for mouse development

Thesis
2025.04.17
Pilot study of autologous multilayered fibroblast sheet transplantation for reinforcing bronchial stump healing after pulmonary lobectomy in a canine model

Thesis
2025.04.08
Innovative Treatment of Ankylosing Dystrophy with a Novel RNA-Targeted Protein

Thesis
2025.03.03
Sodium ferrous citrate in 5-Aminolevulinic acid supplements suppresses the effector function of feline lymphocytes by reducing the mitochondrial membrane potential
The article could not be found.

News
2025.06.13
*Report* Associate Professor Anthony Tosi of Kent State University Visits Kogushi Campus

Thesis
2025.06.12
Riboflavin transporter: Evidence of a role as entry receptor for chimpanzee endogenous retrovirus

News
2025.06.11
*Report* External Lecturer Seminar (Division of Advanced Genome Editing Therapy) was held.

Thesis
2025.06.06
Single bolus injection of nicotinamide mono nucleotide increases systemic insulin sensitivity in association with activation of NAD salvage pathway in the liver and adipose tissue in mice

Thesis
2025.06.05
MXene-Integrated Contact Lens: A Breakthrough in Wearable Eye Protection and Healthcare.

News
2025.05.28
*Information* Seminar co-hosted with the Department of Systems Bioinformatics on June 17

News
2025.05.27
*Report* The 1st Research Institute for Cell Design Medical Science Colloquium was held

News
2025.05.26
*Information* Why can newts “super-regenerate”? Molecular Mechanisms of Organ Regeneration will be held on June 10.
About RICeD
Request for Donations to RICeD
We are promoting the development of cutting-edge cancer immunotherapy to cure many patients.
We are also working to extend the healthy lifespan of both humans and companion animals by applying the world’s first genome editing technology to the treatment of genetic diseases in companion animals and applying the results to human medicine,
We are also working to extend the healthy lifespan of both humans and companion animals by applying the results of our research to human medicine.We sincerely ask for your support to achieve these goals and to continue to promote the practical application of our research results in society.
ー Follow us! ー